Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib
Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE (palbociclib) and talazoparib in Combination with CB-839
Pharmaceutical Investing Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
Noble Mineral highlights Successful Exploration Results announced by Canada Nickel, including Highest Grade to Date at Mann West
CHARBONE Hydrogen and ABB Sign Agreement to Advance North American Green Hydrogen Production Facilities
CHARBONE Hydrogene et ABB signent une entente pour accelerer les usines de production d'hydrogene vert en Amerique du Nord
